v2.4.0.8
G. FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)
 12 Months Ended
Dec. 31, 2013
Fair Value Disclosures [Abstract]  
Schedule of assets and liabilities at fair value

The following table presents a summary of the Company’s financial instruments measured at fair value on a recurring basis as of December 31, 2013 (in thousands):

 

    Quoted prices in active markets for identical assets (Level 1)     Significant other observable remaining inputs (Level 2)     Significant unobservable inputs (Level 3)     Total  
Assets:                                
Cash and cash equivalents   $ 22,006     $ –     $ –     $ 22,006  
Restricted cash     775       –       –       775  
Short term investments     7,970                       7,970  
Total assets   $ 30,751     $ –     $ –     $ 30,751  
Liabilities:                                
Bank acceptance payable           $ 2,347             $ 2,347  
Total liabilities   $ –     $ 2,347     $ –     $ 2,347  

 

The following table presents a summary of the Company’s financial instruments measured at fair value on a recurring basis as of December 31, 2012 (in thousands):

 

    Quoted prices in active markets for identical assets (Level 1)     Significant other observable remaining inputs (Level 2)     Significant unobservable inputs (Level 3)     Total  
Assets:                                
Cash and cash equivalents   $ 10,723     $ –     $ –     $ 10,723  
Restricted cash     503       –       –       503  
Bank acceptance receivable     –       1,034       –       1,034  
Total assets   $ 11,226     $ 1,034     $ –     $ 12,260  
Liabilities:                                
Interest rate swap   $ –     $ 11     $ –     $ 11  
Bank acceptance payable             1,521               1,521  
Total liabilities   $ –     $ 1,532     $ –     $ 1,532